Literature DB >> 24985939

Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.

Somia H Abd-Allah1, Sally M Shalaby1, Amal S El-Shal2, Eman Abd Elkader1, Samia Hussein1, Emad Emam3, Nehad F Mazen4, Mohammed El Kateb5, Mha Atfy6.   

Abstract

BACKGROUND AIMS: The aim of the study was to evaluate the effect of mesenchymal stromal cells (MSCs) on tumor cell growth in vitro and in vivo and to elucidate the apoptotic and anti-proliferative mechanisms of MSCs on a hepatocellular carcinoma (HCC) murine model.
METHODS: The growth-inhibitory effect of MSCs on the Hepa 1-6 cell line was tested by means of methyl thiazolyl diphenyl-tetrazolium assay. Eighty female mice were randomized into four groups: group 1 consisted of 20 mice that received MSCs only by intrahepatic injection; group 2 consisted of 20 HCC mice induced by inoculation of Hepa 1-6 cells into livers without MSC treatment; group 3 consisted of 20 mice that received MSCs after induction of liver cancer; group 4 consisted of 20 mice that received MSCs after induction of liver cancer on top of induced biliary cirrhosis.
RESULTS: MSCs exhibited a growth-inhibitory effect on Hepa 1-6 murine cell line in vitro. Concerning in vivo study, decreases of serum alanine transaminase, aspartate transaminase and albumin levels after MSC transplantation in groups 2 and 3 were found. Gene expression of α-fetoprotein was significantly downregulated after MSC injection in the HCC groups. We found that gene expression of caspase 3, P21 and P53 was significantly upregulated, whereas gene expression of Bcl-2 and survivin was downregulated in the HCC groups after MSC injection. Liver specimens of the HCC groups confirmed the presence of dysplasia. The histopathological picture was improved after administration of MSCs to groups 2 and 3.
CONCLUSIONS: MSCs upregulated genes that help apoptosis and downregulated genes that reduce apoptosis. Therefore, MSCs could inhibit cell division of HCC and potentiate their death.
Copyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MSCs; apoptosis; gene expression; hepatocellular carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24985939     DOI: 10.1016/j.jcyt.2014.05.006

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  8 in total

1.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

2.  Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.

Authors:  Tianran Li; Shaohong Zhao; Bin Song; Zhengmao Wei; Guangming Lu; Jun Zhou; Tianlong Huo
Journal:  Eur J Med Res       Date:  2015-05-24       Impact factor: 2.175

Review 3.  Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?

Authors:  Pascal David Johann; Ingo Müller
Journal:  Stem Cells Int       Date:  2015-07-27       Impact factor: 5.443

4.  Influence of mesenchymal stem cells on metastasis development in mice in vivo.

Authors:  Aleksandra V Meleshina; Elena I Cherkasova; Marina V Shirmanova; Natalia V Klementieva; Ekaterina V Kiseleva; Ludmila В Snopova; Natalia N Prodanets; Elena V Zagaynova
Journal:  Stem Cell Res Ther       Date:  2015-02-27       Impact factor: 6.832

5.  Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells.

Authors:  Chang Liu; Yang Liu; Xiao-Xi Xu; Xin Guo; Guang-Wei Sun; Xiao-Jun Ma
Journal:  BMC Cancer       Date:  2016-07-30       Impact factor: 4.430

6.  Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC.

Authors:  Saieh Hajighasemlou; Mohsen Nikbakht; Saeedreza Pakzad; Samad Muhammadnejad; Safoora Gharibzadeh; Milad Mirmoghtadaei; Fariba Zafari; Iman Seyhoun; Jafar Ai; Javad Verdi
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-14       Impact factor: 2.629

7.  Tracking iron oxide labelled mesenchymal stem cells(MSCs) using magnetic resonance imaging (MRI) in a rat model of hepatic cirrhosis.

Authors:  Abdulwahab Noorwali; Mamdooh Faidah; Naushad Ahmed; Abdulhadi Bima
Journal:  Bioinformation       Date:  2019-01-31

Review 8.  The potential of mesenchymal stem cells in the management of radiation enteropathy.

Authors:  P-Y Chang; Y-Q Qu; J Wang; L-H Dong
Journal:  Cell Death Dis       Date:  2015-08-06       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.